Cytotoxicity inhibitor and cytotoxicity inhibition method
Cytidylic acid and its precursors serve as a novel cytotoxicity inhibitor, promoting cathelicidin production to enhance immune response and reduce cytotoxicity effects.
WO2026141323A1PCT designated stage Publication Date: 2026-07-02YAMASA SHOYU CO LTD
Patent Information
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- YAMASA SHOYU CO LTD
- Filing Date
- 2025-12-22
- Publication Date
- 2026-07-02
AI Technical Summary
Technical Problem
There is a lack of effective and safe inhibitors to prevent cytotoxicity caused by various stressors, including pathogenic microorganisms and internal factors, and existing antimicrobial peptides like cathelicidin have limited studies on their promotion and functionality, particularly with cytidylic acid.
Method used
Cytidylic acid and its precursors are used as active ingredients to inhibit cytotoxicity through a novel mechanism, promoting cathelicidin production and enhancing immune response.
Benefits of technology
Cytidylic acid and its precursors effectively inhibit cytotoxicity by increasing cathelicidin expression, improving immune function, and reducing the duration and severity of cold symptoms.
✦ Generated by Eureka AI based on patent content.
Smart Images
Figure JP2025044905_02072026_PF_FP_ABST
Abstract
The present invention is a cytotoxicity inhibitor containing cytidylic acid and / or a precursor thereof as an active ingredient. One embodiment of the present invention is a cathelicidin production-promoting agent containing cytidylic acid and / or a precursor thereof as an active ingredient.
Need to check novelty before this filing date? Find Prior Art